Risk factors for cancer-associated thrombosis in patients undergoing treatment with immune checkpoint inhibitors
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-0646
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Risk factors for cancer-associated thrombosis in patients undergoing treatment with immune checkpoint inhibitors ; day:10 ; month:12 ; year:2019 ; pages:1-7
Investigational new drugs ; (10.12.2019), 1-7
- Creator
-
Ando, Yosuke
Hayashi, Takahiro
Sugimoto, Reiko
Nishibe, Seira
Ito, Kaori
Kawada, Kenji
Ikeda, Yoshiaki
Yamada, Shigeki
Imaizumi, Kazuyoshi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10637-019-00881-6
- URN
-
urn:nbn:de:101:1-2020040506235136312234
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ando, Yosuke
- Hayashi, Takahiro
- Sugimoto, Reiko
- Nishibe, Seira
- Ito, Kaori
- Kawada, Kenji
- Ikeda, Yoshiaki
- Yamada, Shigeki
- Imaizumi, Kazuyoshi
- SpringerLink (Online service)
Other Objects (12)
Cancer-associated thrombosis in Asia
Safety of Apixaban for Cancer-Associated Thrombosis
Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Erratum: Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Therapeutic Shifts in the Management of Cancer-Associated Thrombosis
Challenging Situations in the Treatment of Cancer-Associated Thrombosis
Proper application of anticoagulation therapy on cancer-associated venous thrombosis
Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives
Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy
Synthetic retinoid-mediated preconditioning of cancer-associated fibroblasts and macrophages improves cancer response to immune checkpoint blockade
NETosis: A New Factor in Tumor Progression and Cancer-Associated Thrombosis
Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis
Cancer-associated thrombosis in Asia
Safety of Apixaban for Cancer-Associated Thrombosis
Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Erratum: Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Therapeutic Shifts in the Management of Cancer-Associated Thrombosis
Challenging Situations in the Treatment of Cancer-Associated Thrombosis
Proper application of anticoagulation therapy on cancer-associated venous thrombosis
Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives
Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy
Synthetic retinoid-mediated preconditioning of cancer-associated fibroblasts and macrophages improves cancer response to immune checkpoint blockade
NETosis: A New Factor in Tumor Progression and Cancer-Associated Thrombosis
Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis
Cancer-associated thrombosis in Asia
Safety of Apixaban for Cancer-Associated Thrombosis
Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Erratum: Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Therapeutic Shifts in the Management of Cancer-Associated Thrombosis
Challenging Situations in the Treatment of Cancer-Associated Thrombosis
Proper application of anticoagulation therapy on cancer-associated venous thrombosis
Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives
Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy
Synthetic retinoid-mediated preconditioning of cancer-associated fibroblasts and macrophages improves cancer response to immune checkpoint blockade
NETosis: A New Factor in Tumor Progression and Cancer-Associated Thrombosis